Daffodil key facts
- Developer of an artificial intelligence-powered platform designed for healthcare pricing and administration.
- It has raised $21.2M; the latest was Early Stage VC ($16.6M) in Dec 2025.
- Notable investors include Flare Capital Partners, Maverick Ventures, EPIC Ventures, Jim Lacy, LRVHealth — 6 tracked in total.
- Status: Privately Held (backing).
- ·Watch Daffodil: the Monday email on marks, rounds and moves
Daffodil funding rounds
No funding rounds for Daffodil are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Daffodil investors
6 investors are on record for Daffodil, including Flare Capital Partners, Maverick Ventures, EPIC Ventures and Jim Lacy.
About Daffodil
Developer of an artificial intelligence-powered platform designed for healthcare pricing and administration. The company's platform specializes in real-time repricing of claims, configuration of pricing rules, and benchmarking of the repriced claims, enabling businesses to have access to automated pricing operations.
- Sector
- Financial Services
- HQ
- San Jose, CA, United States
- Founded
- 2023
- Employees
- 11
- Website
- daffodilhealth.co/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Daffodil doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.